12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

Alchemia, AstraZeneca deal

AstraZeneca partnered with Alchemia to discover and develop small molecules against multiple undisclosed targets provided by the pharma. Alchemia will use its Diversity Scanning Array (DSA)...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >